BiotechTube

MV-012-968

Phase 2Completed
0 watching 0 views this week⚡ Active
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

RSV Infection

Conditions

RSV Infection

Trial Timeline

Dec 29, 2020 → Sep 9, 2021

NCT ID
NCT04690335

About MV-012-968

MV-012-968 is a phase 2 stage product being developed by hVIVO for RSV Infection. The current trial status is completed. This product is registered under clinical trial identifier NCT04690335. Target conditions include RSV Infection.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT04690335Phase 2Completed

Competing Products

20 competing products in RSV Infection

See all competitors
ProductCompanyStageHype Score
BSG005Alkem LaboratoriesPhase 1/2
41
Zotatifin + PlaceboeFFECTOR TherapeuticsPhase 1
25
AAVLP-HPV + Placebo2A PharmaPhase 1
25
CT-P59CelltrionPhase 1
33
CT-P63 + PlaceboCelltrionPhase 1
33
CT-P59 + CT-P59 + Placebo + CT-P59 + PlaceboCelltrionPhase 2/3
65
CT-P59 + PlaceboCelltrionPhase 1
33
SOF + COPEChugai PharmaceuticalPre-clinical
23
Edoxaban Tablets + Colchicine TabletsDaiichi SankyoPhase 3
77
VN-0200 + PlaceboDaiichi SankyoPhase 1
33
VN-0200Daiichi SankyoPhase 2
52
Levofloxacin + Solifenacin succinate + Placebo (for Solifenacin succinate)Astellas PharmaApproved
85
MicafunginAstellas PharmaPhase 1
33
MicafunginAstellas PharmaPre-clinical
23
amphotericin B liposomal (Ambisome)Astellas PharmaApproved
85
Parenteral micafungin application + Other parenteral antifungal drugsAstellas PharmaPre-clinical
23
Fidaxomicin + Treatment for CDI other than fidaxomicin TypeAstellas PharmaPre-clinical
23
Isavuconazonium sulfate + Voriconazole + PosaconazoleAstellas PharmaPre-clinical
23
Ciclosporin and Mycophenolate-mofetil + Tacrolimus and Mycophenolate-mofetil + Tacrolimus and Mycophenolate-mofetil with change from Mycophenolate-mofetil to EverolimusAstellas PharmaApproved
85
DOR/ISLMerckPhase 2
52

Other Products from hVIVO

CC-42344 + PlaceboPhase 2
44
PrEP-001 + G-004Phase 2
44
PrEP-001Phase 2
44
PrEP-001Phase 2
44
SAB-176Phase 2
44